Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Olive Oil and Reduced Lipoprotein (a) Level

Doses used in studies

g/day: 8–20 (median 14, IQR 8–20) — 1 study

Time to effect

Median: 4 weeks · IQR 4 weeks–4 weeks · Range 4 weeks–4 weeks — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
The volumes used (8-20 g/day) reflect typical daily EVOO intake and were well tolerated by participants.
from: Effects of High-Phenolic Extra Virgin Olive Oil (EVOO) on the Lipid Profile of Patients wi

1 of 1 paper

Effects of High-Phenolic Extra Virgin Olive Oil (EVOO) on the Lipid Profile of Patients with Hyperlipidemia: A Randomized Clinical Trial.
- 2025-08-02
- RCT
- Nutrients 17(15)
- - Christos Kourek
  - Emmanouil Makaris
  - Prokopios Magiatis
  - Virginia Zouganeli
  - Vassiliki Benetou
  - Alexandros Briasoulis
  - Andrew Xanthopoulos
  - Ioannis Paraskevaidis
  - Eleni Melliou
  - Georgios Koudounis
  - Philippos Orfanos
- PubMed: 40806126
- DOI: 10.3390/nu17152543
2 Insights on
- Reduced Lipoprotein (a) Level
- High evidence
- Rigorous Journal
- Clinical
... and reduction in Lp(a) (p = 0.040) among hyperlipidemic patients in comparison to healthy individuals.
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
8-20 g/day